BEGIN:VCALENDAR VERSION:2.0 PRODID:-//171.67.215.200//NONSGML kigkonsult.se iCalcreator 2.26.9// CALSCALE:GREGORIAN METHOD:PUBLISH X-FROM-URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar X-WR-TIMEZONE:America/Los_Angeles BEGIN:VTIMEZONE TZID:America/Los_Angeles X-LIC-LOCATION:America/Los_Angeles BEGIN:STANDARD DTSTART:20231105T020000 TZOFFSETFROM:-0700 TZOFFSETTO:-0800 RDATE:20241103T020000 TZNAME:PST END:STANDARD BEGIN:DAYLIGHT DTSTART:20240310T020000 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 RDATE:20250309T020000 TZNAME:PDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:ai1ec-2487@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T041642Z CATEGORIES;LANGUAGE=en-US:Annual Conferences\,Radiology CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://fimh2021.github.i o/ DESCRIPTION:Join us for the 11th biennial International Conference on Funct ional Imaging and Modeling of the Heart (FIMH). FIMH-2021 will celebrate 2 0 years of bringing together friends\, colleagues\, and collaborators to s hare and discuss the latest in cardiac and cardiovascular imaging\, electr ophysiology\, computational modeling\, and translational applications. The event will take place June 21-25\, 2021 virtually\, via Livestream\, Zoom meeting workshops\, and Spatial Chat networking.\n \nSponsored by: Functi onal Imaging and Modeling of the Heart Conference\nTickets: https://www.ev entbrite.com/e/fimh-2021-registration-142940529973?aff=RadiologyExternalCa lendar. DTSTART;VALUE=DATE:20210621 DTEND;VALUE=DATE:20210626 LOCATION:Virtual Event SEQUENCE:0 SUMMARY:International Conference on Functional Imaging and Modeling of the Heart URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/internat ional-conference-on-functional-imaging-and-modeling-of-the-heart/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/FIMH_sidebar_logo-150x150.jpg\;150\;15 0\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp- content/uploads/2019/10/FIMH_sidebar_logo.jpg\;300\;300\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n
\\nJoin us for the 11th b iennial International Conference on Functional Imaging and Modeling of the Heart (FIMH). FIMH-2021 will celebrate 20 years of bringing together friends\, colleagues\, and collaborators to share and discuss the latest i n cardiac and cardiovascular imaging\, electrophysiology\, computational m odeling\, and translational applications. The event will take place June 2 1-25\, 2021 virtually\, via Livestream\, Zoom meeting workshops\, and Spat ial Chat networking.
\n\n
Sponsored by: Functional Imaging and Modeling of the Heart C onference
\nTickets: https://www.eventbrite.com/e/fimh-2021-registration -142940529973?aff=RadiologyExternalCalendar.
X-TICKETS-URL:https://www.eventbrite.com/e/fimh-2021-registration-142940529 973?aff=RadiologyExternalCalendar END:VEVENT BEGIN:VEVENT UID:ai1ec-2677@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T041642Z CATEGORIES;LANGUAGE=en-US:Canary Center CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://www.earlydetectio nresearch.com/ DESCRIPTION:Cancer Research UK\, OHSU Knight Cancer Institute and the Canar y Center at Stanford\, present the Early Detection of Cancer Conference se ries. The annual Conference brings together experts in early detection fro m multiple disciplines to share ground breaking research and progress in t he field.\nThe Conference is part of a long-term commitment to invest in e arly detection research\, to understand the biology behind early stage can cers\, find new detection and screening methods\, and enhance uptake and a ccuracy of screening.\nThe 2021 conference will take place October 6-8 vir tually. For more information visit the website: http://earlydetectionresea rch.com/\nTickets: https://www.earlydetectionresearch.com/virtual-experien ce/. DTSTART;VALUE=DATE:20211006 DTEND;VALUE=DATE:20211009 LOCATION:Virtual Event SEQUENCE:0 SUMMARY:Early Detection of Cancer Conference URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/early-de tection-of-cancer-conference-2/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/EDx21_300x300-150x150.jpg\;150\;150\;1 \,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-cont ent/uploads/2019/10/EDx21_300x300.jpg\;300\;300\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nCancer Research UK\, OHSU Knight Cancer Institute and the Canary Center at Stanford\, present the Early Detection of Cancer Conference series. The annual Conference brings together experts in early detection from multiple disciplines to share ground breaking res earch and progress in the field.
\nThe Conference is part of a long- term commitment to invest in early detection research\, to understand the biology behind early stage cancers\, find new detection and screening meth ods\, and enhance uptake and accuracy of screening.
\nThe 20 21 conference will take place October 6-8 virtually. For more information visit the website: http://earlydetectionresearch.com/
\nTickets: https://www.earlydetectionresearch.com/virtual- experience/.
X-TICKETS-URL:https://www.earlydetectionresearch.com/virtual-experience/ END:VEVENT BEGIN:VEVENT UID:ai1ec-1847@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T041642Z CATEGORIES;LANGUAGE=en-US:SMAC CONTACT:https://med.stanford.edu/smac/events/2nd-annual-disability-conferen ce.html#registration DESCRIPTION:Date: April 10\, 2021 (8 AM-6PM)\n\n\n\n8 AM-8:20 AM opening re marks Zainub and Pete\n8:20 AM-9:20 AM Talk 1 “I fought the law and no one won”\n\n\n10 minute Break\n9:30 AM-10:30 AM talk 2 students and doctors w ith disabilities panel\n\n\n20 minute break\n\n\n\n\n10:50 AM-11:50 AM Bre akout\nOne hour lunch (TBD)\n12:50 PM-1:50 PM Talk 3 the frontiers of dis ability research \n\n\nLisa Meeks is moderating\nBonnie Swenor invited\n\n 10 minute break\n2:00 PM-3:00 PM breakout 2\n\n\n10 minute break\n3:10 PM- 4:10 PM talk 4 do-it-yourself disability advocacy (Poullos/Tolchin with st udents)\n\n\n4:10 PM-4:30 PM closing remarks\n\n\n4:30 PM-6 PM virtual hap py hour\n\n \n \nTickets: https://med.stanford.edu/smac/events/2nd-annual- disability-conference.html#registration. DTSTART;TZID=America/Los_Angeles:20210410T080000 DTEND;TZID=America/Los_Angeles:20210410T180000 SEQUENCE:0 SUMMARY:Stanford School of Medicine’s 2nd Annual Conference on Disability i n Healthcare and Medicine URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/stanford -school-of-medicines-2nd-annual-conference-on-disability-in-healthcare-and -medicine/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2020/10/Screen-Shot-2021-03-04-at-10.39.22-AM- e1614883544333-150x150.jpeg\;150\;150\;1\,medium\;http://web.stanford.edu/ group/radweb/cgi-bin/radcalendar/wp-content/uploads/2020/10/Screen-Shot-20 21-03-04-at-10.39.22-AM-e1614883544333-300x300.jpeg\;300\;300\;1\,large\;h ttp://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads /2020/10/Screen-Shot-2021-03-04-at-10.39.22-AM-e1614883443684-1024x1024.jp eg\;640\;640\;1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2020/10/Screen-Shot-2021-03-04-at-10.39.22-AM-e16 14883544333.jpeg\;883\;883\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nDate: April 10\, 2021 (8 AM-6PM)< /span>
\n\n
\n
Tickets: https://med.stanford.edu/smac/events/2nd-an nual-disability-conference.html#registration.
X-TICKETS-URL:https://med.stanford.edu/smac/events/2nd-annual-disability-co nference.html#registration END:VEVENT BEGIN:VEVENT UID:ai1ec-2363@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T041642Z CATEGORIES;LANGUAGE=en-US:Radiology CONTACT: DESCRIPTION:Radiology Department-Wide Research Meeting\n• Research Announce ments\n• Michelle James\, PhD – Detecting and Tracking Immune Responses in the Brain and Beyond using PET\n• Ryan Spitler\, PhD – Precision Health a nd Integrated Diagnostics (PHIND) Center\nLocation: Zoom – Details can be found here: https://radresearch.stanford.edu\nMeetings will be the 3rd Fri day of each month.\n \nHosted by: Brian Hargreaves\, PhD\nSponsored by: th e the Department of Radiology DTSTART;TZID=America/Los_Angeles:20210416T120000 DTEND;TZID=America/Los_Angeles:20210416T130000 SEQUENCE:0 SUMMARY:Radiology-Wide Research Meeting URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/radiolog y-wide-research-meeting-4/ X-COST-TYPE:free X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2021/03/research-meeting-150x150.png\;150\;150 \;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-c ontent/uploads/2021/03/research-meeting-300x133.png\;300\;133\;1\,large\;h ttp://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads /2021/03/research-meeting.png\;628\;278\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nRadiology Department- Wide Research Meeting
\n• Research Announcements
\n• M
ichelle James\, PhD – Detecting and Tracking Immune Responses in the Brain
and Beyond using PET
\n• Ryan Spitler\, PhD – Precision Health and I
ntegrated Diagnostics (PHIND) Center
Location: Zo
om – Details can be found here: https://radresearch.stanford.edu
\nMeetings will be the 3rd Frid
ay of each month.
\n
Hosted by: Brian Hargreaves\, PhD<
/em>
\nSponsored by: the the Department of Radiology
MIPS Semi nar Series: Emerging nanophotonic platforms for infectious di sease diagnostics: Re-imagining the conventional microbiology toolkit
\nJennifer
Dionne\, PhD
\nSenior Associate Vice
Provost for Research Platforms/Shared Facilities
\nAssociate Professor of Material Science and Engineering a
nd\, by courtesy\, of Radiology (Molecular Imaging Program at Stanford)
\nStanford University
\n
Location: Zoom
\nWe
binar URL: https://stanford.zoom.us/j/95883654314
\nDial: +1
650 724 9799 or +1 833 302 1536
\nWebinar ID: 958 8365 4314
\nPa
sscode: 105586
12:00pm – 12:45pm Seminar & Discussion
\nRSVP Here
\n
ABSTRACT
\nWe present our research controlling light at the nanoscale for infecti
ous disease diagnostics\, including detecting bacteria at low concentratio
n\, sensing COVID gene sequences\, and visualizing in-vivo inter-cellular
forces. First\, we combine Raman spectroscopy and deep learning to accurat
ely classify bacteria by both species and antibiotic resistance in a singl
e step. We design a convolutional neural network (CNN) for spectral data a
nd train it to identify 30 of the most common bacterial strains from singl
e-cell Raman spectra\, achieving antibiotic treatment identification accur
acies exceeding 99% and species identification accuracies similar to leadi
ng mass spectrometry identification techniques. Our combined Raman-CNN sys
tem represents a proof-of-concept for rapid\, culture-free identification
of bacterial isolates and antibiotic resistance. Second\, we describe res
onant nanophotonic surfaces\, known as “metasurfaces” that enable multiple
xed detection of SARS-CoV-2 gene sequences. Our metasurfaces utilize guide
d mode resonances excited in high refractive index nanostructures. The hig
h quality factor modes produce a large amplification of the electromagneti
c field near the nanostructures that increase the response to targeted bin
ding of nucleic acids\; simultaneously\, the optical signal is beam-steere
d for multiplexed detection. We describe how this platform can be manufact
ured at scale for portable\, low-cost assays. Finally\, we introduce a new
class of in vivo optical probes to monitor biological forces wit
h high spatial resolution. Our design is based on upconverting nanoparticl
es that\, when excited in the near-infrared\, emit light of a different co
lor and intensity in response to nano-to-microNewton forces. The nanoparti
cles are sub-30nm in size\, do not bleach or photoblink\, and can enable d
eep tissue imaging with minimal tissue autofluorescence. We present the de
sign\, synthesis\, and characterization of these nanoparticles both in vit
ro and in vivo\, focusing on the forces generated by the roundworm C.
elegans as it feeds and digests its bacterial food.
\n
ABOUT
\nJennifer Dionne is the Senior Associate Vic
e Provost of Research Platforms/Shared Facilities and an associate profess
or of Materials Science and Engineering and\, by courtesy\, of Radiology a
t Stanford. She is also an Associate Editor of Nano Letters\, director of
the DOE-funded Photonics at Thermodynamic Limits Energy Frontier Research
Center\, and an affiliate faculty of the Wu Tsai Neurosciences Institute\,
the Institute for Immunity\, Transplantation\, and Infection\, and Bio-X.
Jen received her B.S. degrees in Physics and Systems Science and Mathemat
ics from Washington University in St. Louis\, her Ph. D. in Applied Physic
s at the California Institute of Technology in 2009\, and her postdoctoral
training in Chemistry at Berkeley. Her research develops nanophotonic me
thods to observe and control chemical and biological processes as they unf
old with nanometer scale resolution\, emphasizing critical challenges in g
lobal health and sustainability. Her work has been recognized with the Ala
n T. Waterman Award\, a NIH Director’s New Innovator Award\, a Moore Inven
tor Fellowship\, the Materials Research Society Young Investigator Award\,
and the Presidential Early Career Award for Scientists and Engineers\, an
d was featured on Oprah’s list of “50 Things that will make you say ‘Wow’!
”. Beyond the lab\, Jen enjoys exploring the intersection of art and scie
nce\, long-distance cycling\, and reliving her childhood with her two youn
g sons.
\n
Hosted by: Katherine Ferrara\, PhD
\nSponsored by: Molecular Imaging Program at Stanford & the Departmen
t of Radiology
Tickets: https://stanford.zoom.us/webinar/register/7416069513520/WN_ LIAnoCzYR8yLOnO-CDPgIQ.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7416069513520/WN_LI AnoCzYR8yLOnO-CDPgIQ END:VEVENT BEGIN:VEVENT UID:ai1ec-2417@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T041642Z CATEGORIES;LANGUAGE=en-US:Canary Center\,IBIIS\,MIPS\,PHIND\,Radiology\,RSL CONTACT:Marta Flory\; flory@stanford.edu DESCRIPTION:Targeted violence continues against Black Americans\, Asian Ame ricans\, and all people of color. The department of radiology diversity co mmittee is running a racial equity challenge to raise awareness of systemi c racism\, implicit bias and related issues. Participants will be provided a list of resources on these topics such as articles\, podcasts\, videos\ , etc.\, from which they can choose\, with the “challenge” of engaging wit h one to three media sources prior to our session (some videos are as shor t as a few minutes). Participants will meet in small-group breakout sessio ns to discuss what they’ve learned and share ideas.\nPlease reach out to M arta Flory\, flory@stanford.edu with questions. For details about the sess ion\, including recommended resources and the Zoom link\, please reach out to Meke Faaoso at mfaaoso@stanford.edu.\nTickets: https://docs.google.com /spreadsheets/d/1ehKqHm32peHcm7NQJ427OaKIa9JpfHVunjBk66etZGc/edit?usp=shar ing. DTSTART;TZID=America/Los_Angeles:20210430T120000 DTEND;TZID=America/Los_Angeles:20210430T130000 LOCATION:Zoom SEQUENCE:0 SUMMARY:Racial Equity Challenge: Race in society URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/racial-e quity-challenge-race-in-society/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2021/04/shield-150x150.png\;150\;150\;1\,mediu m\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl oads/2021/04/shield.png\;225\;225\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nTargeted violence continues against Black Ameri cans\, Asian Americans\, and all people of color. The department of radiol ogy diversity committee is running a racial equity challenge to raise awar eness of systemic racism\, implicit bias and related issues. Participants will be provided a list of resources on these topics such as articles\, po dcasts\, videos\, etc.\, from which they can choose\, with the “challenge” of engaging with one to three media sources prior to our session (some vi deos are as short as a few minutes). Participants will meet in small-group breakout sessions to discuss what they’ve learned and share ideas.
\n< p>Please reach out to Marta Flory\, fl ory@stanford.edu with questions. For details about the session\, inclu ding recommended resources and the Zoom link\, please reach out to Meke Fa aoso at mfaaoso@stanford.edu.\n X-TICKETS-URL:https://docs.google.com/spreadsheets/d/1ehKqHm32peHcm7NQJ427O aKIa9JpfHVunjBk66etZGc/edit?usp=sharing END:VEVENT BEGIN:VEVENT UID:ai1ec-1757@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T041642Z CATEGORIES;LANGUAGE=en-US:Canary Center\,Early Cancer Detection Seminar Ser ies CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://canarycenter.stan ford.edu/seminars.html DESCRIPTION:CEDSS: “Building a Scalable Clinical Genomics Program: How tumo r\, normal\, and plasma DNA sequencing are informing cancer care\, cancer risk\, and cancer detection”\n \nMichael Berger\, Ph.D.\nElizabeth and Fel ix Rohatyn Chair & Associate Director of the Marie-Josée and Henry R. Krav is Center for Molecular Oncology\nMemorial Sloan Kettering Cancer Center\n \nZoom Details\nMeeting URL: https://stanford.zoom.us/s/92559505314\nDial : US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)\nMeeting ID: 925 595 0 5314\nPasscode: 418727\n11:00am – 12:00pm Seminar & Discussion\nRSVP Her e\n \nABSTRACT\nTumor molecular profiling is a fundamental component of pr ecision oncology\, enabling the identification of oncogenomic mutations th at can be targeted therapeutically. To accelerate enrollment to clinical t rials of molecularly targeted agents and guide treatment selection\, we ha ve established a center-wide\, prospective clinical sequencing program at Memorial Sloan Kettering Cancer Center using a custom\, paired tumor-blood normal sequencing assay (MSK-IMPACT)\, which we have used to profile more than 50\,000 patients with solid tumors. Yet beyond just the characteriza tion of tumor-specific alterations\, the inclusion of blood DNA has readil y enabled the identification of germline risk alleles and somatic mutation s associated with clonal hematopoiesis. To complement this approach\, we h ave also implemented a ‘liquid biopsy’ cfDNA panel (MSK-ACCESS) for cancer detection\, surveillance\, and treatment selection and monitoring. In my talk\, I will describe the prevalence of somatic and germline genomic alte rations in a real-world population\, the clinical benefits of cfDNA assess ment\, and how clonal hematopoiesis can inform cancer risk and confound li quid biopsy approaches to cancer detection.\n \nABOUT\nMichael Berger\, Ph D\, holds the Elizabeth and Felix Rohatyn Chair and is Associate Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Me morial Sloan Kettering Cancer Center\, a multidisciplinary initiative to p romote precision oncology through genomic analysis to guide the diagnosis and treatment of cancer patients. He is also an Associate Attending Geneti cist in the Department of Pathology with expertise in cancer genomics\, co mputational biology\, and high-throughput DNA sequencing technology. His l aboratory is developing experimental and computational methods to characte rize the genetic makeup of individual cancers and identify genomic biomark ers of drug response and resistance. As Scientific Director of Clinical NG S in the Molecular Diagnostics Service\, he oversees the development and b ioinformatics associated with clinical sequencing assays\, and he helped l ead the development and implementation of MSK-IMPACT\, a comprehensive FDA -authorized tumor sequencing panel that been used to profile more than 60\ ,000 tumors from advanced cancer patients at MSK. The resulting data have enabled the characterization of somatic and germline biomarkers across man y cancer types and the identification of mutations associated with clonal hematopoiesis. Dr. Berger also led the development of a clinically validat ed plasma cell-free DNA assay\, MSK-ACCESS\, which his laboratory is using to explore tumor evolution\, acquired drug resistance\, and occult metast atic disease. He received his Bachelor’s Degree in Physics from Princeton University and his Ph.D. in Biophysics from Harvard University.\n \nHosted by: Utkan Demirci\, Ph.D.\nSponsored by: The Canary Center & the Departme nt of Radiology \nStanford University – School of Medicine\nTickets: https ://stanford.zoom.us/webinar/register/5516153318622/WN_MT7TTEciRoWmLVP9GlsJ RA. DTSTART;TZID=America/Los_Angeles:20210511T110000 DTEND;TZID=America/Los_Angeles:20210511T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:Cancer Early Detection Seminar Series – Michael Berger\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cancer-e arly-detection-seminar-series-michael-f-berger-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/berger_160204_07-2_3x2-150x150.jpg\;15 0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/berger_160204_07-2_3x2-300x200.jpg\;300\;200\ ;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-con tent/uploads/2019/10/berger_160204_07-2_3x2.jpg\;600\;400\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nCEDSS: “Building a Scalable Clinical Genomics Program: How tumor\, normal\, and plasma DNA se quencing are informing cancer care\, cancer risk\, and cancer detection” em>
\n\n\n
Elizabeth and Fel
ix Rohatyn Chair & Associate Director of the Marie-Josée and Henry R. Krav
is Center for Molecular Oncology
\nMemorial Sloan Kettering Cancer Ce
nter
\n
Zoom Details
\nMeeti
ng URL: https://stanford.zoom.us/s/92559505314
\nDial: US: +1
650 724 9799 or +1 833 302 1536 (Toll Free)
\nMeeting ID: 925 5950
5314
\nPasscode: 418727
11:00am – 12:00pm Seminar & Discussio
n
\nRSVP Here
\n
ABSTRAC
T
\nTumor molecular profiling is a fundamental component of
precision oncology\, enabling the identification of oncogenomic mutations
that can be targeted therapeutically. To accelerate enrollment to clinical
trials of molecularly targeted agents and guide treatment selection\, we
have established a center-wide\, prospective clinical sequencing program a
t Memorial Sloan Kettering Cancer Center using a custom\, paired tumor-blo
od normal sequencing assay (MSK-IMPACT)\, which we have used to profile mo
re than 50\,000 patients with solid tumors. Yet beyond just the characteri
zation of tumor-specific alterations\, the inclusion of blood DNA has read
ily enabled the identification of germline risk alleles and somatic mutati
ons associated with clonal hematopoiesis. To complement this approach\, we
have also implemented a ‘liquid biopsy’ cfDNA panel (MSK-ACCESS) for canc
er detection\, surveillance\, and treatment selection and monitoring. In m
y talk\, I will describe the prevalence of somatic and germline genomic al
terations in a real-world population\, the clinical benefits of cfDNA asse
ssment\, and how clonal hematopoiesis can inform cancer risk and confound
liquid biopsy approaches to cancer detection.
\n
AB
OUT
\nMichael Berger\, PhD\, holds the Elizabeth and Felix R
ohatyn Chair and is Associate Director of the Marie-Josée and Henry R. Kra
vis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Cente
r\, a multidisciplinary initiative to promote precision oncology through g
enomic analysis to guide the diagnosis and treatment of cancer patients. H
e is also an Associate Attending Geneticist in the Department of Pathology
with expertise in cancer genomics\, computational biology\, and high-thro
ughput DNA sequencing technology. His laboratory is developing experimenta
l and computational methods to characterize the genetic makeup of individu
al cancers and identify genomic biomarkers of drug response and resistance
. As Scientific Director of Clinical NGS in the Molecular Diagnostics Serv
ice\, he oversees the development and bioinformatics associated with clini
cal sequencing assays\, and he helped lead the development and implementat
ion of MSK-IMPACT\, a comprehensive FDA-authorized tumor sequencing panel
that been used to profile more than 60\,000 tumors from advanced cancer pa
tients at MSK. The resulting data have enabled the characterization of som
atic and germline biomarkers across many cancer types and the identificati
on of mutations associated with clonal hematopoiesis. Dr. Berger also led
the development of a clinically validated plasma cell-free DNA assay\, MSK
-ACCESS\, which his laboratory is using to explore tumor evolution\, acqui
red drug resistance\, and occult metastatic disease. He received his Bache
lor’s Degree in Physics from Princeton University and his Ph.D. in Biophys
ics from Harvard University.
\n
Hosted by: Utkan Demirc
i\, Ph.D.
\nSponsored by
: The Canary Center & the Department of Radiology
\nStanfor
d University – School of Medicine
Tickets: https://stanford.zoom.us/webinar/registe r/5516153318622/WN_MT7TTEciRoWmLVP9GlsJRA.
X-TICKETS-URL:https://stanford.zoom.us/webinar/register/5516153318622/WN_MT 7TTEciRoWmLVP9GlsJRA END:VEVENT BEGIN:VEVENT UID:ai1ec-2385@web.stanford.edu/group/radweb/cgi-bin/radcalendar DTSTAMP:20240330T041642Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; ashleylw@stanford.edu\; https://med.stanford.edu/ mips/events.html DESCRIPTION:MIPS Special Seminar: Jubilant Biosys: Drug discovery and contr act research services\, from target discovery to candidate selection\n \nT homas Haywood\, PhD\nHead of International Radiochemistry Collaborations\n Stanford University\n \nSaurabh Kapure\, MBA\nVice President\, Business De velopment (USA & APAC)\nJubilant Biosys Limited\n \nJay Sheth\, MBA\nManag er Business Development\, Drug Discovery Services\, and CDMO\nJubilant Bio sys Limited\n \nLOCATION: Zoom\nMeeting URL: https://stanford.zoom.us/j/98 108346345\nDial: +1 650 724 9799 or +1 833 302 1536\nMeeting ID: 981 0834 6345\nPasscode: 397741\n\n\nSCHEDULE\n9:00-9:15 AM\, PT – Thomas Haywood – Stanford Radiology projects\n9:15-9:30 AM\, PT – Saurabh Kapure – Introd uction to Jubilant Biosys\, Scale-up and GMP manufacturing\n9:30-9:40 AM\, PT – Jay Sheth – How Jubilant Biosys works with academic partners: exampl es and case-studies\n9:40-10:00 AM\, PT – Moderated by Jason Thanh Lee – Discussion\n \nABOUT\nJubilant Biosys\, an integrated contract research or ganization in India with business offices in Asia and North America\, is a leading collaborator for biotechnology and pharmaceutical companies\, wit h in-depth expertise in discovery informatics\, medicinal chemistry\, stru ctural biology\, and in vitro pharmacology services. Jubilant Biosys provi des comprehensive drug discovery services and contract research services\, from target discovery to candidate selection and with flexible business m odels (FFS\, FTE and risk shared). This seminar will showcase case studies from recent Stanford projects and a discussion of future opportunities.\n \nSponsored by: Molecular Imaging Program at Stanford\, Department of Rad iology DTSTART;TZID=America/Los_Angeles:20210512T090000 DTEND;TZID=America/Los_Angeles:20210512T100000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Special Seminar – Jubilant Biosys URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-spe cial-seminar-jubilant-biosys/ X-COST-TYPE:free X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/Headshots-for-Calendar-150x150.jpg\;15 0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/Headshots-for-Calendar.jpg\;210\;209\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n\\nMIPS Special Seminar: < /strong>Jubilant Biosys: Drug discovery and contract research services \, from target discovery to candidate selection
\n\n
\nHead of International Radiochemi
stry Collaborations
\nStanford University
\n
S
aurabh Kapure\, MBA
\nVice President\, Business Development
(USA & APAC)
\nJubilant Biosys Limited
\n
Jay
Sheth\, MBA
\nManager Business Development\, Drug Discovery
Services\, and CDMO
\nJubilant Biosys Limited
\n
ABOUT Sponsored by: Molecular Imaging Program at Stanford\, D
epartment of Radiology Radiology Department-W
ide Research Meeting • Research Announcements Location: Zoom – Details can be found here: https://radresearch.stanfor
d.edu <
/p>\n Hosted by: Daniel Ennis\, PhD MIPS Semina
r Series: Image-guided focal therapy for prostate cancer Location: Zoom 12:00pm – 12:4
5pm Seminar & Discussion <
/p>\n ABSTRACT In recent years\, prostate cance
r treatment has increasingly focused on selecting patients who are most li
kely to benefit and reducing harms from treatment. This has been seen both
in adoption of active surveillance for men with low-risk prostate cancer
and emergence of image-guided focal ablative therapy. While focal therapy
causes fewer sexual and urinary side effects than conventional prostate ca
ncer treatments\, many questions remain about proper patient selection\, t
reatment planning\, and follow up care. Improvements in prostate MRI performance and interpretation have paved th
e way for adoption of focal therapy. However\, clinical challenges remain
in prostate cancer imaging. This talk will describe prostate cancer focal
therapy\, discuss patient selection\, and highlight the research efforts o
f my group to improve MRI interpretation to guide biopsy and improve focal
therapy performance. ABOUT Dr. Sonn was born in Washington State and l
ived there until leaving for college at Georgetown. After graduating magna
cum laude at Georgetown he returned to the West Coast for medical school
at UCLA. Following medical school\, Dr. Sonn completed a 6-year urology re
sidency at Stanford where he developed particular interests in the clinica
l care of patients with urologic cancers and research in cancer imaging. D
r. Sonn completed a 2-year urologic oncology fellowship at UCLA. Since com
pleting his fellowship\, Dr. Sonn has been at Stanford as an assistant pro
fessor in urology. Dr. Sonn’s research is devoted to developing new cancer
imaging techniques\, applying artificial intelligence to find cancers on
medical images\, and applying new methods to treat prostate cancer with fe
wer side effects. Hosted by: Katherine Ferrara\, PhD
Tickets: https://stanford.zoom.us/webinar/register/8116097
828282/WN_mfyC-_dUTwymWGqvmmF1zA. Molecular I
maging in Neuroscience – MIPS Mini-Retreat Hosted by: Dr. Michelle L. James\, PhD Sponsored by: Departme
nt of Radiology\, Molecular Imaging Program at Stanford The M
IPS Mini-retreat series brings together members of the MIPS and greater Sc
hool of Medicine community to discuss current opportunities for research a
nd collaborations. During each mini-retreat we will discuss a different to
pic and we invite all those interested to attend. The mini-retreats are ro
ughly two hours in length with ample time for discussion throughout. We ho
pe you can join us and spark new collaborations! Zoom Webinar Information Tentative Agenda (all times ar
e in PST) Radiology Department-Wide Research Meeting •
Research Announcements Location: Zoom – Details can be found here: https://radresearch.st
anford.edu Hosted by: Kawin Setsompop\, PhD Dr. Sanjiv Sam Gambhir was a v
isionary who had a profound impact on the world of science and humanity. A
s a leader and pioneer in the fields of molecular imaging\, early detectio
n of cancer\, and precision health\, his enduring legacy can be seen in th
e research and innovations continuing in these fields today. The G
ambhir Symposium aims to celebrate Dr. Gambhir’s illustrious career and co
ntinue down the paths he forged by highlighting the work still ongoing in
the fields he helped to cultivate. Join us to hear researchers and collabo
rators share current thoughts and future outlooks on topics developed with
Sam. We hope you can join us for the 2021 Virtual Gambhir Symposi
um. The event is fully virtual and the livestream link wil
l be posted on the website closer to the event. Sponsored by: Department of Radio
logy at Stanford Tickets: https://www
.onlineregistrationcenter.com/Gambhir2021. CME Grand Rounds Sanjiv S
am Gambhir Lectureship – “Imaging at the Speed of Light: Innovations
in Positron Emission Tomography” Simon R. C
herry\, PhD Join from PC\, Mac\, Linux\, iOS o
r Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1q
VkxyL3U0RmNtUDVWdz09 ABSTRACT Positron emission tomograph
y (PET) allows for sensitive and quantitative measurement of physiology\,
metabolism and molecular targets noninvasively in the human body. However
\, typical clinical PET scanners capture less than 1% of the available sig
nal produced in the body. PET scanners also are not currently capable of
precisely determining the location at which a particular decay occurs. The
se limitations present opportunities for further innovation that ultimatel
y will impact molecular imaging research and diagnostic imaging with PET.
This presentation focuses on 1) total-body PET imaging which greatly impr
oves signal collection\, allowing radiotracer kinetics to be assessed acro
ss the entire human body for the first time\, and 2) the development of de
tector technologies that have a timing precision of ~ 30 picoseconds\, ena
bling direct localization of radiotracer decays without tomographic recons
truction. BIO Simon R. Cherry\,
Ph.D. received his B.Sc.(Hons) in Physics with Astronomy from University
College London in 1986 and a Ph.D. in Medical Physics from the Institute
of Cancer Research\, University of London in 1989. After a postdoctoral f
ellowship at UCLA\, he joined the faculty in the Department of Molecular a
nd Medical Pharmacology\, also at UCLA\, in 1993. In 2001\, Dr. Cherry joi
ned UC Davis and established the Center for Molecular and Genomic Imaging\
, which he directed from 2004-2016. Currently Dr. Cherry is Distinguished
Professor in the Departments of Biomedical Engineering and Radiology at UC
Davis. Dr. Cherry’s research interests center around biomedical i
maging and in particular the development and application of in vivo molecu
lar imaging systems. His major accomplishments have been in developing sy
stems for positron emission tomography (PET)\, in particular the invention
of the microPET technology that was subsequently widely adopted in academ
ia and industry and as co-leader of the EXPLORER consortium which has deve
loped the world’s first total-body PET scanner. He also has contributed t
o detector technology innovations for PET\, conducted early biomedical stu
dies using Cerenkov luminescence\, and developed the first proof-of-concep
t hybrid PET/MRI (magnetic resonance imaging) systems. Dr. Cherry
is a founding member of the Society of Molecular Imaging and an elected fe
llow of six professional societies\, including the Institute for Electroni
c and Electrical Engineers (IEEE) and the Biomedical Engineering Society (
BMES). He served as Editor-in-Chief of the journal Physics in Medicine and
Biology from 2011-2020. Dr. Cherry received the Academy of Molecular Imag
ing Distinguished Basic Scientist Award (2007)\, the Society for Molecular
Imaging Achievement Award (2011) and the IEEE Marie Sklodowska-Curie Awar
d (2016). In 2016\, he was elected as a member of the National Academy o
f Engineering and in 2017 he was elected to the National Academy of Invent
ors. Dr. Cherry is the author of more than 240 peer-reviewed journal arti
cles\, review articles and book chapters in the field of biomedical imagin
g. He is also lead author of the widely-used textbook “Physics in Nuclear
Medicine”. MIPS Semi
nar Series: Predicting and Preventing Fetal and Neonatal Path
ology: Looking Back and Looking Forward David K. Stevenson\, MD Zoom Webinar Details 12:00p
m – 12:45pm Seminar & Discussion ABSTRACT ABOUT Hosted by: Katherine Ferrara\,
PhD Tickets: https://stanford.zoom.us/webinar/register/711
6294064170/WN_H60DZOKZSlWC6UBOB3FTVw. CME Grand Rounds Diversity Lectureship –
Topic: TBD Jennifer L. Eberhardt\, PhD Join from PC\, Mac\, Linux\, iOS or Android: https://
stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09 ABSTRACT
BIO CME Grand Rounds – “Commun
ity Based Partnered Research: Revisiting a Critical Concept for Radiology
” Christoph L. Lee\, MD\, MS\, MBA Join from PC\, Mac\, Linux\, iOS or Android: https://stanf
ord.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09 ABSTRACT BIO CEDSS: The First Cell: A new model
for cancer research and treatment Azra Raza\, M.D. L
ocation: Zoom ABSTRACT Cancer research continues to
be predicated on a 1970’s model of research and treatment. Despite half a
century of intense research\, we are failing spectacularly to improve the
outcome for patients with advanced disease. Those who are cured continue
to be treated mostly with the older strategies (surgery-chemo-radiation).
Our contention is that the real solution to the cancer problem is to diagn
ose cancer early\, at the stage of The First Cell. The rapidly evolving te
chnologies are doing much in this area but need to be expanded. We study a
pre-leukemic condition called myelodysplastic syndrome (MDS) with the hop
e that we can detect the first leukemia cells as the disease transforms to
acute myeloid leukemia (AML). Towards this end\, we have collected blood
and bone marrow samples on MDS and AML patients since 1984. Today\, our Ti
ssue Repository has more than 60\,000 samples. We propose novel methods to
identify surrogate markers that can identify the First Cell through study
ing the serial samples of patients who evolve from MDS to AML.
p>\n ABOUT Dr. Raza is a Professor of Medicine
and Director of the MDS Center at Columbia University in New York\, NY.She
started her research in Myelodisplastic Syndromes (MDS) in 1982 and moved
to Rush University\, Chicago\, Illinois in 1992\, where she was the Charl
es Arthur Weaver Professor in Oncology and Director\, Division of Myeloid
Diseases. The MDS Program\, along with a Tissue Repository containing more
than 50\,000 samples from MDS and acute leukemia patients was successfull
y relocated to the University of Massachusetts in 2004 and to Columbia Uni
versity in 2010. Before moving to New York\, Dr. Raza was the Chie
f of Hematology Oncology and the Gladys Smith Martin Professor of Oncology
at the University of Massachussetts in Worcester. She has published the r
esults of her laboratory research and clinical trials in prestigious\, pee
r reviewed journals such as The New England Journal of Medicine\, Nature\,
Blood\, Cancer\, Cancer Research\, British Journal of Hematology\, Leukem
ia\, and Leukemia Research. Dr. Raza serves on numerous national and inter
national panels as a reviewer\, consultant and advisor and is the recipien
t of a number of awards. Hosted by: Utkan Demirci\,
Ph.D. Alone in the Ring (a research-based
theatre production about inclusive healthcare workplaces) is coming to ca
mpus during the Annual Stanford School of Medicine Diversity Week and Nati
onal Disability Employment Awareness Month\, SMAC and Stanford Medicine and the Muse
hope to continue the discussion on how to spark and sustain change towards
inclusive workspaces. Alone in the Ring is followed by a discussio
n between the team and audience members. During the presentation\, audienc
e members are encouraged to reflect: How inclusive is your workspace? How
could you make it more accessible? CME Grand Rounds – Topic: TBD Jocelyn D. Chertoff\, MD\, MS Join from PC\, Mac\, Linux\, iOS or A
ndroid: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkx
yL3U0RmNtUDVWdz09
ABSTRACT
BIO Office of Faculty Development and Diversity and
SMAC. The OFDD team welcomes all Stanford community members t
o join our inaugural Health Equity Action Leadership (HEAL Network) event\, Hea
lth Equity Research in the Latinx Community\, where faculty who do this wo
rk will share their experiences in a fireside chat panel. Moderato
r: Lisa Goldman-Rosas Speakers: Dr. Ken Sutha\, Dr. Peter Poullos\
, Dr. Holly Tabor MIPS Seminar Series: Title TBA Steven Paul Poplack\, MD Location: Coming soon! 12:00pm – 12:45pm Seminar & Discussion\nRSVP: Coming soon! ABSTRACT Coming soon! ABOUT Hosted by: Katherine Ferrara\, PhD CME Grand Rounds Etta K. Moskowitz Lecturesh
ip – Topic: TBD Elizabeth Krupinski\, PhD Join from PC\,
Mac\, Linux\, iOS or Android: https://stanford.zoom.us/j/6000037
03?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09 ABSTRACT BIO CME Grand Rounds
– “Promote Your Academic Career Using Social Media” Michae
l Gisondi\, MD
Join from PC\, Mac\, Linux\, iOS or Android: https://stanford.zo
om.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09 ABSTRACT\nComing soon! BIO MIPS Seminar Ser
ies: Title TBA Matthew Bogyo\, PhD Location: Coming soon!
p>\n 12:00pm – 12:45pm Seminar & Discussion ABSTRACT Coming soon!
p>\n ABOUT Hosted by: Katherine Ferrara\, PhD
\nMeeting URL: https://stanford.zoom.us/j/9
8108346345
\nDial: +1 650 724 9799 or +1 833 302 1536
\nMeeting ID: 981 0834 6345
\nPasscode: 397741
p>\n\n\n
\n9:
00-9:15 AM\, PT – Thomas Haywood – Stanford Radiolo
gy projects
\n9:40-10:00 AM\, PT – Moderated by Jason Thanh Le
e – Discussion
\nJubilant Biosys\, an integrated contract research organization i
n India with business offices in Asia and North America\, is a leading col
laborator for biotechnology and pharmaceutical companies\, with in-depth e
xpertise in discovery informatics\, medicinal chemistry\, structural biolo
gy\, and in vitro pharmacology services. Jubilant Biosys provides
comprehensive drug discovery services and contract research services\, fr
om target discovery to candidate selection and with flexible business mode
ls (FFS\, FTE and risk shared). This seminar will showcase case studies fr
om recent Stanford projects and a discussion of future opportunities.
\n• Ko
en Nieman\, M.D.\, PhD – Coronary Artery Disease by Computed Tomography
\n• Martin Willemink\, M.D.\, PhD – Translating Emerging Cardiovascular
CT Techniques into the Clinical Setting
\nMeetings will be the 3rd Friday of each month.
\nSponsored by: th
e the Department of Radiology
\nWebinar URL: https://stanford.zoom.u
s/s/96126703618
\nDial: +1 650 724 9799 or +1 833 302 1536
\nWebinar ID: 961 2670 3618
\nPasscode: 186059
\nRSVP Here
\nGeof
frey Sonn\, MD is a urologic oncologist who specializes in treating patien
ts with prostate and kidney cancer. He has a particular interest in cancer
imaging\, MRI-Ultrasound fusion targeted prostate biopsy\, prostate cance
r focal therapy\, and robotic surgery for prostate and kidney cancer. He i
s the principal investigator of the first clinical trial in Northern Calif
ornia to use MRI-guided focused ultrasound to treat prostate cancer. The g
oal of this trial is to treat prostate cancer with fewer side effects than
surgery or radiation.
\nSponsored by: Molecular Imaging Program at Stanford & the
Department of Radiology
\nWebinar URL: htt
ps://stanford.zoom.us/j/92903233643
\nDial: US: +1 650 724 9799
or +1 833 302 1536 (Toll Free)
\nWebinar ID: 929 0323 3643
\nPas
scode: 146018
\n8:00-8:05 AM – Opening Rem
arks – Michelle Jam
es\, PhD
\n8:05-8:55 AM – Overview and Imaging-b
ased Collaboration: Department of Neurology\, Neurosurgery\, Pathology\, P
sychiatry\, and Nuclear Medicine (Frank M. Longo\, MD\, PhD\, Michael Lim\, MD\, Thomas Montine\, MD\, PhD\, Victor G. Carrión\, MD\, and Guido Davidzon\, MD)\n8:55-9:20 AM – Faculty Introductions: All inter
ested MIPS faculty on the call give a 2-minute introduction including thei
r interest in collaborating with Neurology\, Pathology\, Neurosurgery\, an
d/or Psychiatry and Behavioral Sciences departments.
\n9
:20-9:40 AM – Recent center proposals and possible mechanisms: UD
ALL Collaboration – Michelle James\, PhD and Kathleen Poston\, MD\, MS
\n9:40-10:00
AM – Discussion – Moderated by: Michelle James\, PhD and Katherine Ferrara\, PhD
\n• Mirabela Rusu\, PhD – Learning MRI Signat
ures of Aggressive Prostate Cancer: Bridging the Gap between Digital Patho
logists and Digital Radiologists
\n• Akshay Chaudhari\, PhD – Data-Ef
ficient Machine Learning for Medical Imaging
\nMeetings will be the 3rd Friday of each month.
\nSponsore
d by: the the Department of Radiology
\nProfessor
\nBiomedical Engineering & Radi
ology
\nUC Davis
\nMeeting ID: 600 003 703
\nPassword: 5
66048
\nOr iPhone one-tap (US Toll): +18333021536\,\,600003703# or +1
6507249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799
(US\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbea
n Toll Free)
\nInternational numbers available: https://stanford.zoom.us/u/acuqphnvqT
\nThe
Harold K. Faber Professor of Pediatrics\, Senior Associate Dean\, Maternal
and Child Health and Professor\, by courtesy\, of Obstetrics and Gynecolo
gy
\nLucile Packard Children’s Hospital
\nWebinar URL: https://stanfo
rd.zoom.us/s/94584828060
\nDial: +1 650 724 9799 or +1 833 302 15
36
\nWebinar ID: 945 8482 8060
\nPasscode: 481874
\nRSVP Here
\nThe importance of minimal
ly invasive technologies for interrogating the fetus and newborn\, as well
as of knowing where a biologic system is headed\, not just where it has b
een\, when trying to predict and prevent acquired diseases\, will be discu
ssed. Examples of such technologies\, such as trace gas analysis and opti
cal reporting of biologic phenomena\, and their application to model syste
ms and the human newborn will be presented. The role of advanced computat
ional approaches for the integration and interpretation of large amounts o
f data derived from these new measurement tools will be emphasized.
\nDr. David K. Stevenson is the Ha
rold K. Faber Professor of Pediatrics and has made many impactful contribu
tions to the field of neonatology and pediatrics\, including his seminal s
tudies on neonatal jaundice\, bilirubin production and heme oxygenase biol
ogy. As a neonatologist\, his research has focused primarily on neonatal
jaundice and more recently on the causes of preterm birth and its preventi
on. He has held numerous leadership roles at Stanford University School o
f Medicine\, including Vice Dean and Senior Associate Dean for Academic Af
fairs. He is currently the Senior Associate Dean for Maternal & Child Heal
th\, the Co-Director of the Stanford Maternal & Child Health Research Inst
itute\, and the Principal Investigator for the March of Dimes Prematurity
Research Center at Stanford University. Dr. Stevenson has received many a
wards\, including the Virginia Apgar Award\, which is the highest award in
Perinatal Pediatrics\, the Joseph W. St. Geme\, Jr. Leadership Award from
the Federation of Pediatric Organizations\, the Jonas Salk Award for Lead
ership in Prematurity Prevention from the March of Dimes Foundation\, and
the John Howland Medal and Award\, the highest award in academic pediatric
s. He has served as the President of the American Pediatric Society. In r
ecognition of his achievements\, Dr. Stevenson is a member of the National
Academy of Medicine.
\nSponsored by: Molecular Imaging Program at Stanford &
the Department of Radiology
\nProfessor
\nPsychology
\nStanford University
\nMeeting ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-ta
p (US Toll): +18333021536\,\,600003703# or +16507249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Tol
l) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternati
onal numbers available: ht
tps://stanford.zoom.us/u/acuqphnvqT
\nComing soon!
\nComing soon!
\nProfessor
\nRadiology
\nUniversity of Washington
\nMe
eting ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-tap (US
Toll): +18333021536\,\,600003703# or +16507249799\,\,600003703#
\nOr
Telephone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or
+1 833 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternational
numbers available: https:/
/stanford.zoom.us/u/acuqphnvqT
\nComing soon!
\nCom
ing soon!
\nChan
Soon-Shiong Professor of Medicine
\nDirector\, Myelodysplastic Syndro
me Center
\nColumbia University Medical Center
\nMeeting URL: https:
//stanford.zoom.us/s/99340345860
\nDial: US: +1 650 724 9799 or
+1 833 302 1536 (Toll Free)
\nMeeting ID: 993 4034 5860
\nPassco
de: 711508
\nSponsored by: Th
e Canary Center & the Department of Radiology
\nStanford Un
iversity – School of Medicine
\nProfessor
\nRadiology\
, Obstetrics & Gynecology
\nChair\, Radiology
\nDartmouth Hitchc
ock Medical Center
\nMeeting ID: 600 003 703
\nPassword: 5660
48
\nOr iPhone one-tap (US Toll): +18333021536\,\,600003703# or +1650
7249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 (U
S\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbean T
oll Free)
\nInternational numbers available: https://stanford.zoom.us/u/acuqphnvqT
\nComing soon!
\nComing soon!
\nProfessor of Radiology
(Breast Imaging)
\nStanford University Medical Center
\nComing soo
n!
\n
\n
Professor & Vice Chair for Research
\nRadiology & Imaging Sciences
\nEmory University School of Medicine
\nMeeting ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-tap (US Toll): +18333021536\
,\,600003703# or +16507249799\,\,600003703#
\nOr Telephone:
\nDi
al: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\
, Canada\, Caribbean Toll Free)
\nInternational numbers available: https://stanford.zoom.us/u/a
cuqphnvqT
\nComing so
on!
\nComing soon!
\nAssociate Professor & Vice Chair of Educati
on
\nEmergency Medicine
\nStanford University
\nMeeting
ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-tap (US Toll)
: +18333021536\,\,600003703# or +16507249799\,\,600003703#
\nOr Telep
hone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1 83
3 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternational number
s available: https://stanf
ord.zoom.us/u/acuqphnvqT
\nComing so
on!
\nProfessor of Pathology and of M
icrobiology and Immunology and\, by courtesy\, of Chemical and Systems Bio
logy
\nStanford University
\nRSVP: Coming soon!
\nDr. Bogyo received a B.Sc. degree in
Chemistry from Bates College in 1993 and a Ph.D. in Biochemistry from the
Massachusetts Institute of Technology in 1997. After completion of his deg
ree he was appointed as a Faculty Fellow in the Department of Biochemistry
and Biophysics at the University of California\, San Francisco. Dr. Bogyo
served as the Head of Chemical Proteomics at Celera Genomics from 2001 to
2003 while maintaining an Adjunct Faculty appointment at UCSF. In the Sum
mer of 2003 Dr. Bogyo joined the Department of Pathology at Stanford Medic
al School and was appointed as a faculty member in the Department of Micro
biology and Immunology in 2004. His interests are focused on the use of ch
emistry to study the role of proteases in human disease. In particular his
laboratory is currently working on understanding the role of cysteine pro
teases in tumorgenesis and also in the life cycle of human parasites and b
acterial pathogens. Dr. Bogyo currently serves on the Editorial Board of B
iochemical Journal\, Cell Chemical Biology\, Molecular and Cellular Proteo
mics and is an Academic Editor at PLoS One. Dr. Bogyo is a consultant for
several biotechnology and pharmaceutical companies in the Bay Area and is
a founder and board member of Akrotome Imaging and Facile Therapeutics.
\nSpo
nsored by: Molecular Imaging Program at Stanford & the Department of Radio
logy